Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 16.1519.1713.5429.1926.12

What is the latest EV/Core EBITDA ratio of GLAND PHARMA ?

The latest EV/Core EBITDA ratio of GLAND PHARMA is 16.15 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202516.15
Mar202419.17
Mar202313.54
Mar202229.19
Mar202126.12

How is EV/Core EBITDA of GLAND PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 16.15
-15.75
Mar2024 19.17
41.58
Mar2023 13.54
-53.61
Mar2022 29.19
11.75
Mar2021 26.12 -

Other Financial Ratios of GLAND PHARMA


Compare EV/Core EBITDA ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹32,392.3 Cr 3.8% 1.5% 0% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,167.0 Cr NA -0.9% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.8%

1.5%

0%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses